ONTTF.US Oxford Nanopore Technologies Limited

Healthcare Biotechnology USA Stocks
2.62 USD
Close of Nov 15, 2026
1.27 3.18
Market cap
USD 2.57B
P/E
-
P/B
4.56x
ROE
-45.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is ONTTF.US undervalued?

Graham number

The Graham number of Oxford Nanopore Technologies Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Oxford Nanopore Technologies Limited fundamental analysis

No fundamental analysis for Oxford Nanopore Technologies Limited yet.

Oxford Nanopore Technologies Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Oxford Nanopore Technologies Limited

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, suc…

Full company profile